Scott Mccall

Title: Scott McCall: Innovator in Oligonucleotide Separation Technologies

Introduction

Scott McCall is a notable inventor based in Smithfield, Rhode Island, with a focus on advancements in the field of oligonucleotide separation technologies. He holds two patents that contribute significantly to this area of research and development. His work is primarily associated with Waters Technologies Corporation, a leading company in analytical instruments and software.

Latest Patents

Scott McCall's latest patents revolve around the use of polyanionic acids to enhance recovery and minimize system loss during the separation of oligonucleotides. The technology involves a method where a polyphosphonic acid is injected into a sample containing oligonucleotides at a concentration ranging from about 0.01 M to about 1 M. This method includes flowing the sample and polyphosphonic acid through a liquid chromatography column, effectively separating the oligonucleotides for improved analysis.

Career Highlights

Throughout his career, Scott has made significant contributions to the field of biotechnology and analytical chemistry. His innovative approaches have led to advancements that benefit researchers and industries relying on precise oligonucleotide analysis. His work at Waters Technologies Corporation has positioned him as a key player in the development of cutting-edge technologies.

Collaborations

Scott McCall has collaborated with notable colleagues, including Michael Donegan and Martin Gilar. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented technologies.

Conclusion

Scott McCall's contributions to the field of oligonucleotide separation technologies through his patents and work at Waters Technologies Corporation highlight his role as an influential inventor. His innovative methods continue to advance the capabilities of analytical chemistry, benefiting various research applications.